Vesugen 10mg – Endothelial Cell Function & Vascular Homeostasis Research

Description

What is Vesugen & CAS 147732-56-7?

The evolution of cardiovascular gerontology is rooted in the development of short-chain peptides that target specific tissue types. Vesugen (CAS 147732-56-7) is a synthetic tripeptide composed of Lys-Glu-Asp (Lysyl-Glutamyl-Aspartic Acid). It was originally developed to function as a vascular bioregulator, specifically designed to mimic the natural regulatory signals within the vessel walls. By interacting with the genetic markers of vascular cells, Vesugen allows researchers to observe the biochemical pathways associated with endothelial health and the structural maintenance of the circulatory system.

Supplied in an ultra-stable, vacuum-sealed lyophilized format, our Vesugen 10mg vials are engineered for maximum durability. Maintaining the structural integrity of this tripeptide is crucial for laboratory precision. At 99Purity-Peptide, we utilize a professional-grade freeze-drying process that prevents the hydrolytic cleavage common in liquid bioregulators, ensuring that each 10mg unit remains a high-fidelity subject for micro-circulation research.

Vesugen Mechanism of Action and Research

The primary laboratory utility of Vesugen is centered on its ability to modulate protein synthesis within the vascular endothelium. At the cellular level, the functionality of this tripeptide involves the normalization of DNA expression in the cells of the vessel walls. In various experimental models, scientists have observed how Vesugen influences the restoration of the vascular intima, helping to maintain optimal permeability and reducing the inflammatory markers associated with chronic vascular aging.

Contemporary academic explorations are currently focused on the peptide’s impact on angiogenesis and systemic micro-circulation. By evaluating how Vesugen triggers the regeneration of capillaries and larger vessels, researchers are gaining insights into the potential deceleration of atherosclerosis-related biological markers. Its role in optimizing the metabolic activity of the vascular system makes it a foundational subject for studies involving cardiovascular longevity and organ-specific blood flow.

Trending Research Topics & High-Authority Insights:

• Endothelial Function and Bioregulation: Investigating the genetic triggers of vascular repair.

• Micro-vascular Density in Aging Models: Studies on the restoration of capillary networks.

Vesugen Specifications

Vesugen Key Features & Benefits

• Targeted Vascular Bioregulator: Optimized for research into the regeneration of blood vessel walls and endothelial lining.

• Micro-circulation Focus: A specialized tool for studying the optimization of systemic blood flow and capillary density.

• Pharmaceutical Grade Synthesis: Produced at 99%+ purity to ensure experimental noise is eliminated in longevity models.

• Enhanced Freeze-Dried Stability: Vacuum-sealed to resist environmental degradation and extend the research shelf life significantly.

• Independently Verified Identity: Each batch is confirmed via HPLC to guarantee absolute chemical identity and sequence precision.

Vesugen Research FAQ

How does Vesugen interact with the vascular endothelium in studies?

In a laboratory setting, Vesugen is researched for its ability to reduce the accumulation of “cellular waste” within the endothelium. Researchers observe how the tripeptide interacts with DNA sequences to promote the synthesis of proteins that maintain vessel flexibility and structural integrity.

Why is 10mg the standard strength for vascular bioregulator research?

The 10mg configuration provides a precise baseline for titration in cellular health experiments. This allows researchers to create standardized solutions for investigating the dose-response relationship between peptide concentration and vascular wall regeneration markers.

What is the recommended storage for Vesugen 10mg after reconstitution?

To ensure maximum structural integrity, reconstituted Vesugen should be kept in a sterile environment at 2-8°C. Scientists typically use the solution within 10 days to maintain the highest fidelity for research, as the short-chain peptide is most active before any gradual hydrolysis occurs.

Can Vesugen be studied in combination with other bioregulators?

Yes. Many research protocols explore the synergy between Vesugen (vascular focus) and peptides like Ventfort or Crystagen to observe how multi-organ bioregulation impacts systemic biological aging and circulatory efficiency.

Why Buy Vesugen online from 99Purity-Peptide?

• Scientific Grade Consistency: We prioritize the chemical precision required for high-fidelity research, ensuring every vial of Vesugen meets our rigorous 99%+ purity benchmark.

• Reliable Batch-to-Batch Quality: Our manufacturing protocols ensure that the chemical profile and folding of our Vesugen remain identical in every vial, supporting credible long-term research results.

• Discreet & Tracked Logistics: Your research privacy is a priority. All orders feature unbranded, secure packaging with expedited tracked shipping to the USA, UK, and Europe.

• Consumer Rights & Transparency: From 3rd-party lab verification (COA) to 1-2 business day dispatch, we provide the professional reliability that modern biotechnology researchers demand.

Payment Support & Logistics

• Secure Payment Options: We support multiple secure gateways, including Credit Cards, Cryptocurrency (USDT, USDC), PayPal, and Bank Transfers.

• Global Shipping: Fast, tracked delivery available to the United States, United Kingdom, and Europe.

• Processing Time: All orders are professionally handled and dispatched within 1-2 business days after payment confirmation.

Regulatory Disclaimer

99Purity-Peptide is a chemical supplier. We are not a compounding pharmacy or an outsourcing facility as defined under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act). All products are strictly for research, laboratory, or analytical use only and are NOT for human consumption.

References & Academic Links

• Khavinson, V. K., et al. (2011). “Peptide regulation of vascular endothelial function during aging.” Advances in Gerontology.

• Lezhava, T., et al. (2010). “Epigenetic modulation of vascular cell aging by synthetic tripeptides.” Biogerontology.

• Labunets, I. F. (2014). “Bioregulators and the cardiovascular system: A clinical review.” Project Topaz Research Archives.

• Morozov, V. G., et al. (2000). “Short peptides as regulators of gene expression.” PubMed – Bulletin of Experimental Biology and Medicine.